A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

If you're not paying close attention, the first stage can be easy to miss. COPD treatment goal is to help you breathe easier and help regular activities. Medications along with lifestyle ...

“Patients with mild-to-moderate COPD who have low exercise tolerance are likely to experience poor respiratory health outcomes,” the investigators concluded. “Exercise tolerance may be considered one ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, ...

To diagnose chronic obstructive pulmonary disease (COPD), doctors typically use spirometry to measure your lung function. They usually also perform other tests to monitor the damage to your lungs.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...